Company: STAA
Filing Date: 2025-11-06
Form Type: DFAN14A
Source: 0001213900-25-107231
Chunk: 1

Company: STAAR SURGICAL CO
Filing Date: 2025-11-06
Form: DFAN14A
Chunk 1
---
 of the Company in connection with the special meeting of stockholders
scheduled for October 23, 2025 (including any adjournments, postponements, reschedulings or continuations thereof, the “Special
Meeting”). The Participants have filed a definitive proxy statement on Schedule 14A (the “Definitive Proxy Statement”)
and accompanying GREEN Proxy Card to be used in connection with any such solicitation of proxies from the Company’s
stockholders for the Special Meeting. STOCKHOLDERS OF THE COMPANY ARE URGED TO READ THESE MATERIALS (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) AND ANY OTHER RELEVANT DOCUMENTS THAT THE PARTICIPANTS HAVE FILED OR WILL FILE WITH THE U.S. SECURTIES AND EXCHANGE COMMISSION (THE “SEC”) BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION, INCLUDING ABOUT THE MATTERS TO BE VOTED ON AT THE SPECIAL MEETING AND additional information relating to the Participants and their direct or indirect interests, by security holdings or otherwise. The Definitive Proxy Statement and accompanying GREEN Proxy
Card have been furnished to some or all of the Company’s stockholders and will be, along with other relevant documents, available
at no charge on the SEC’s website at https://www.sec.gov/.

Information about the Participants and a description
of their direct or indirect interests, by security holdings or otherwise, is contained on an amendment to Schedule 13D filed by the Participants
with the SEC on October 24, 2025 and is available here.

Exhibit 1

Exhibit 2

<div align='center'>Yunqi Capital Applauds STAAR Surgical’s Strong Third Quarter Results and Reiterates That the Proposed Sale to Alcon Should Be Terminated

Performance Reflects Strong ICL Demand and Validates Shareholder Opposition to the Proposed Merger

Deferring to Alcon to Solicit Proxies for the Proposed Merger Will Not Relieve STAAR’s Board of Its Credibility Deficit with Shareholders</div>

HONG KONG--(BUSINESS WIRE)--Yunqi Capital Limited (together with its
affiliates and the funds it advises, “Yunqi Capital”), an investment management firm and 5.1% shareholder of STAAR Surgical
Company (“STAAR” or the “Company”) (NASDAQ:STAA), today released the following letter to the Board of Directors
of STAAR after reviewing STAAR’s third quarter earnings press release and